Arthur He HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
15
Avg Return
Past Year
Past Year
63%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
78.6%
Neutral
21.4%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $110 |
192%
upside
| 4 | +17% |
0
%
| 2 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $165 |
80%
upside
| 3 | +176% |
0
%
| 10 Feb ‘26 2 months ago |
|
|
|
Buy
Initiated
| $25 |
0%
upside
| 1 | +9.1% |
0
%
| 7 Jan ‘26 3 months ago |
|
|
|
Buy
Maintained
| $7 |
90%
upside
| 2 | +64% |
0
%
| 15 Aug ‘25 8 months ago |
|
|
|
Neutral
Maintained
| $1.24 |
29%
downside
| 2 | +37% |
–
| 5 Aug ‘25 8 months ago |
|
|
|
Buy
Assumed
| $17 |
6%
upside
| 1 | +61% |
0
%
| 30 Jul ‘25 9 months ago |
|
|
|
Neutral
Downgraded
| – | – | 2 | -49% |
0
%
| 29 Jul ‘25 9 months ago |
|
|
|
Buy
Reiterated
| $20 |
153%
upside
| 1 | +50% |
0
%
| 17 Jun ‘25 10 months ago |
|
|
|
Neutral
Downgraded
| – | – | 2 | -24% |
0
%
| 20 May ‘25 11 months ago |
|